Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: A nationwide multicenter study

Journal of Clinical Neurology (Korea)

Volumn 10, Issue 2, 2014, Pages 94-100

  Kim, Jong Kuk ^a   Bae, Jong Seok ^b   Kim, Dae Seong ^c   Kusunoki, Susumu ^d   Kim, Jong Eun ^c   Kim, Ji Soo ^e   Park, Young Eun ^c   Park, Ki Jong ^f   Song, Hyun Seok ^g   Kim, Sun Young ^h   Lim, Jeong Geun ⁱ   Kim, Nam Hee ^j   Suh, Bum Chun ^k   Nam, Tai Seung ^l   Park, Min Su ^m   Choi, Young Chul ⁿ   Sohn, Eun Hee ^o   Na, Sang Jun ^p   Huh, So Young ^q   Kwon, Ohyun ^r   Lee, Su Yun ^a   Lee, Sung Hoon ^b   Oh, Sun Young ^s   Jeong, Seong Hae ^o   Lee, Tae Kyeong ^t   Kim, Dong Uk ^u   more..

^a Dong A University   (South Korea)

^b Hallym University   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d KINKI UNIVERSITY   (Japan)

^e Seoul National University   (South Korea)

^f Gyeongsang National University   (South Korea)

^g Kyungpook National University School of Medicine   (South Korea)

^h University of Ulsan College of Medicine   (South Korea)

ⁱ Keimyung University   (South Korea)

^j Dongguk University College of Medicine   (South Korea)

^k Sungkyunkwan University   (South Korea)

^l Chonnam National University Medical School   (South Korea)

^m Yeungnam University College of Medicine   (South Korea)

ⁿ Yonsei University College of Medicine   (South Korea)

^o Chungnam National University   (South Korea)

^p Konyang University   (South Korea)

^q Kosin University   (South Korea)

^r Eulji University   (South Korea)

^s Chonbuk National University   (South Korea)

^t Soonchunhyang University   (South Korea)

^u Chosun University College of Medicine   (South Korea)

more..

Author keywords

Acute motor axonal neuropathy; Antibodies; Ganglioside; Guillain barr ; Korea; Syndrome

Indexed keywords

EID: 84897507806     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2014.10.2.94     Document Type: Article

References (36)

1. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27 Suppl:S21-S24.
2. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet 2005; 366:1653-1666.
3. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 1996;39:424-431.
4. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, et al. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 2001;49:712-720.
5. Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 2007;35:691-711.
6. Sekiguchi Y, Uncini A, Yuki N, Misawa S, Notturno F, Nasu S, et al. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study. J Neurol Neurosurg Psychiatry 2012;83:23-28.
7. Uncini A, Manzoli C, Notturno F, Capasso M. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 2010;81:1157-1163.
8. Lee SH, Lim GH, Kim JS, Oh SY, Kim JK, Cha JK, et al. Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody. Neurology 2008;71:426-429.
9. Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Clinical correlates of serum anti-GT1a IgG antibodies. J Neurol Sci 2004;219:139-145.
10. Miyazaki T, Kusunoki S, Kaida K, Shiina M, Kanazawa I. Guillain- Barré syndrome associated with IgG monospecific to ganglioside GD1b. Neurology 2001;56:1227-1229.
11. Kusunoki S, Chiba A, Kon K, Ando S, Arisawa K, Tate A, et al. Nacetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-576.
12. Nagashima T, Koga M, Odaka M, Hirata K, Yuki N. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch Neurol 2007;64:1519-1523.
13. Koga M, Yuki N, Hirata K. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom. J Neurol Neurosurg Psychiatry 1999;66:513-516.
14. Paparounas K. Anti-GQ1b ganglioside antibody in peripheral nervous system disorders: pathophysiologic role and clinical relevance. Arch Neurol 2004;61:1013-1016.
15. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-55.
16. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992;31:677-679.
17. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125(Pt 12):2591-2625.
18. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978;2:750-753.
19. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998; 44:780-788.
20. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995; 118(Pt 3):597-605.
21. Oh SJ, Kim DE, Kuruoglu HR. What is the best diagnostic index of conduction block and temporal dispersion? Muscle Nerve 1994;17: 489-493.
22. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000;48:624-631.
23. Odaka M, Yuki N, Yoshino H, Kiso M, Ishida H, Hirata K. Antibodies to GD1alpha and to GQ1beta in Guillain-Barré syndrome and the related disorders. J Neurol Sci 1999;165:126-132.
24. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, et al. Anti- GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999;45:168-173.
25. Willison HJ. Gangliosides as targets for autoimmune injury to the nervous system. J Neurochem 2007;103 Suppl 1:143-149.
26. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007;27:3956-3967.
27. Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, et al. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 2007;55:746-757.
28. Kashihara K, Shiro Y, Koga M, Yuki N. IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical- brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1998;65:799.
29. Koga M, Yuki N, Ariga T, Morimatsu M, Hirata K. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J Neuroimmunol 1998;86:74-79.
30. Susuki K, Koga M, Hirata K, Isogai E, Yuki N. A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol 2009;256: 1899-1905.
31. Gong Y, Tagawa Y, Lunn MP, Laroy W, Heffer-Lauc M, Li CY, et al. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain 2002;125(Pt 11):2491-2506.
32. Galassi G, Susuki K, Quaglino D, Yuki N. Post-infectious acute ataxia and facial diplegia associated with anti-GD1a IgG antibody. Eur J Neurol 2004;11:790-791.
33. Kim SY, Kim JK, Suh CK. Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome. J Clin Neurosci 2013;20:473-475.
34. Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998;44:202-208.
35. Kim JK, Kim DS, Kusunoki S, Kim SJ, Yoo BG. Acute pure motor demyelinating neuropathy with hyperreflexia and anti-GalNAc-GD1a antibodies. Clin Neurol Neurosurg 2012;114:1345-1347.
36. Hong YH, Sung JJ, Oh MY, Moon HJ, Park KS, Lee KW. Axonal conduction block at intermediate nerve segments in pure motor Guillain- Barré syndrome. J Peripher Nerv Syst 2011;16:37-46.